The Machines Are Coming (And Lawsuits Too): Mitigating Risks of Device Design, Manufacture, and Sale Amidst the AI Revolution
Explore the latest regulatory trends impacting AI and machine learning-enabled medtech devices in this free webinar.
Learn more about our Regulatory Affairs work.
Explore the latest regulatory trends impacting AI and machine learning-enabled medtech devices in this free webinar.
Join us in Washington, D.C. for our Cybersecurity Summit that will address the future of medical device cybersecurity and changes in the industry landscape related to FDA requirements.
Explore the various factors and considerations at play in determining whether a CDS product is likely to be actively regulated.
Register for the 16th Annual King & Spalding Medical Device Summit in Chicago!
Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
Gear up for success with the “Recall Rediness” webinar by IQVIA & AdvaMed. Learn how to ease internal loads, ensuring efficient and compliant recalls.
Uncover pivotal medtech go-to-market insights in our free webinar. Explore healthcare leaders’ views on industry trends, investments, and vendor interactions.
Ethylene oxide sterilization ensures billions of pieces of medical technology are sterile for patients in every medical setting, in surgical procedures from c-sections to knee replacements.
According to a senior toxicologist in a RealClearPolicy op-ed, the EPA draws unreasonable conclusions about the health risks of the ethylene oxide used to sterilize medical technology.
This AdvaMed position statement is intended to provide clarity about the transition away from the acronyms NDC/NHRIC to NRC, including rationale and implications.